Novartis7h
Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)
About Fabhalta® (iptacopan) Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.
allAfrica.com on MSN13h
Navigating Challenges and Unveiling Possibilities for Nigeria's Livestock Sector
Nigeria's Minister of Livestock Development, Alhaji Idi Mukhtar Maiha, had, at a Ministerial Press Briefing, expressed his ambitious vision of doubling the livestock sector's contribution to the Gross ...